Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease
Journal of Clinical Laboratory Analysis · 2023-04 · 37 (8)
DOI: 10.1002/jcla.24890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 09.05.2023. Verfasst von Shiji Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Zhongshan Hospital Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Graves Disease, Hyperthyroidism. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai Medical Key Specialty, Specialized Fund for the Clinical Researches of Zhongshan Hospital Affiliated Fudan University, the constructing project of clinical key disciplines in Shanghai.
Abstract (Originalsprache)
Objective
To evaluate thyroid‐stimulating immunoglobulin (TSI) and thyrotropin receptor antibodies (TRAb) diagnostic performance for Graves' disease (GD) and determine clinical cut‐off value for diagnosing GD.
Methods
Of 1369 retrospectively enrolled subjects, 1364 had a definitive diagnosis of untreated GD (GD‐UT, n = 87); treated GD (GD‐T, n = 206); autoimmune thyroid disease (AIT, n = 241); thyroid nodules (TN, n = 677); subacute thyroiditis (ST, n = 28); healthy subjects (HS, n = 125); other diseases with serological hyperthyroidism ( n = 5) and were grouped into the following: UT‐GD and control groups (AIT, TN, ST, and HS); and UT‐GD and non‐GD hyperthyroidism groups. Diagnostic performance of TSI and TRAb was evaluated using area under the curve (AUC) of receiver‐operating characteristic (ROC) curve, and optimal clinical cut‐off value was determined using maximization of Youden index.
Results
TRAb AUC and clinical cut‐off value for diagnosing GD were 0.981 and 1.245 IU/L (sensitivity, 96.6%; specificity, 97.1%; positive predictive value [PPV], 71.8%; negative predictive value [NPV], 99.9%; positive likelihood ratio [PLR], 33.31; negative likelihood ratio [NLR, 0.035), respectively, for the GD‐UT and control groups. Those for TSI were 0.992 and 0.467 IU/L (sensitivity 98.8%; specificity, 96.4%; PPV, 68.8%; NPV, 99.9%; PLR, 27.472; NLR, 0.011). Those for TRAb in GD‐UT and non‐GD hyperthyroidism groups were 0.923 and 1.78 IU/L (sensitivity, 92.0%; specificity, 89.1%; PPV, 93%; NPV, 87.5%; PLR, 8.44; NLR, 0.089), respectively. For TSI, these were 0.92 and 0.545 IU/L (sensitivity, 97.7%; specificity, 83.6%; PPV, 90.4%; NPV, 95.8%; PLR27.472, NLR, 0.011), respectively.
Conclusion
TSI diagnostic performance for GD was excellent and had better sensitivity than TRAb.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Zhongshan Hospital Fudan University, Shanghai, China.
ORCID-Profile: Beili Wang, Wei Guo
Förderung
- Shanghai Medical Key Specialty
- Specialized Fund for the Clinical Researches of Zhongshan Hospital Affiliated Fudan University
- the constructing project of clinical key disciplines in Shanghai
- The National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Xu, S., Shao, W., Wu, Q., Zhu, J., Pan, B., Wang, B., & Guo, W. (2023). Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease. Journal of Clinical Laboratory Analysis, 37(8). https://doi.org/10.1002/jcla.24890
Vancouver
Xu S, Shao W, Wu Q, Zhu J, Pan B, Wang B, et al. Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease. Journal of Clinical Laboratory Analysis. 2023;37(8). doi:10.1002/jcla.24890
BibTeX
@article{Xu2023,
author = {Xu, Shiji and Shao, Wenqi and Wu, Qun and Zhu, Jing and Pan, Baishen and Wang, Beili and Guo, Wei},
title = {Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease},
journal = {Journal of Clinical Laboratory Analysis},
year = {2023},
volume = {37},
number = {8},
doi = {10.1002/jcla.24890}
}
EUVIMED